Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-06 Sale |
2023-03-08 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
77,421 | $9.5536 | $739,653 | 165,381 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 07:33 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
59,655 | $9.8866 | $589,785 | 182,727 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
10,897 | $7.4082 | $80,727 | 408,324 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:43 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
4,862 | $8.1422 | $39,587 | 134,149 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:06 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
4,138 | $9.0602 | $37,491 | 124,912 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
6,012 | $10.57 | $63,523 | 205,646 (Direct) |
View |
| 2021-03-03 Sale |
2021-03-04 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
606 | $10.86 | $6,583 | 70,058 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
7,486 | $10.83 | $81,079 | 121,302 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
29,657 | $12.69 | $376,481 | 72,539 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-04 Exercise |
2023-03-07 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
77,421 | $0 | 507,925 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
99,601 | $0 | 507,925 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:33 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
59,655 | $0 | 182,727 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:02 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
42,309 | $0 | 42,309 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
76,821 | $0 | 408,324 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
154,155 | $0 | 408,324 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:43 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
17,346 | $0 | 134,149 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
13,135 | $0 | 124,912 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
37,939 | $0 | 124,912 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
13,930 | $0 | 205,646 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
99,809 | $0 | 205,646 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
1,400 | $0 | 70,058 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
17,346 | $0 | 121,302 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
13,135 | $0 | 72,539 (Direct) |
View |
| 2021-02-09 Option Award |
2021-02-11 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
55,287 | $0 | 72,539 (Direct) |
View |